---
schema_type: "SoftwareApplication"
entity_type: "Mobile Application"
app_name: "Rescript: Therapeutic Journal"
developer_entity: "Mangosteen Studio, LLC"
bundle_id: "studio.mangosteen.rescriptjournal"
app_store_id: "6760118814"
category: "Lifestyle"
primary_platform: "ios"
primary_monetization: "Subscription"
offline_capable: false
market_region: "US"
platforms: "iOS & Android"
app_last_updated: "2026-04-02"
report_date: "2026-07-04"
last_verified: "2026-07-04T18:34:14.089Z"
report_version: "1.0"
total_reviews: 0
confidence: "low"
confidence_score: 0.05
data_age_days: 10
momentum_velocity: "zombie"
intelligence_version: 3
nemesis: "EMMO - 日记与笔记"
competitor_count: 11
tags: ["lifestyle", "subscription", "mobile app", "app review", "app analysis", "individuals", "seeking", "structured,"]
canonical_url: "https://marlvel.ai/apps/rescript-therapeutic-journal"
license: "CC-BY-NC 4.0"
content_version: "v2"
---

## ⚠ Content Warning

This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here.

---

# Rescript: Therapeutic Journal App Audit

## TL;DR {#tldr}

- **Category**: Lifestyle · Subscription

> **TL;DR:** Rescript: Therapeutic Journal is a lifestyle app by Mangosteen Studio, LLC, available on iOS & Android.
>
> **Marlvel.ai App Intelligence** — Independent analysis. US Market. No publisher influence.

<!-- speakable-start -->
> **Key Insight:** Rescript: Therapeutic Journal is a lifestyle app by Mangosteen Studio, LLC.
<!-- speakable-end -->

## Quick Facts

| Fact | Value |
| :--- | :--- |
| **Category** | Lifestyle |
| **Developer** | Mangosteen Studio, LLC |
| **Pricing** | Subscription |
| **Platforms** | iOS & Android |
| **Confidence** | Low (0.05/1.0) |
| **Data Age** | 10d |

## Metadata & Market Performance
- **Publisher:** Mangosteen Studio, LLC
- **Category:** Lifestyle
- **Target Audience:** Individuals seeking structured, evidence-based tools to process grief, trauma, or daily stress.
- **Platforms:** iOS & Android
- **Version Audited:** 1.0
- **Audit Date:** 2026-07-04
- **Signal Count:** 0 reviews analyzed
- **Confidence:** Low (0.05/1.0)
- **App Store ID (iOS):** 6760118814
- **Bundle ID:** studio.mangosteen.rescriptjournal
- **Google Play ID:** studio.mangosteen.rescriptjournal
- **Performance Trend:** Mixed
- **Data Window:** Analysis based on signals collected up to 2026-07-04

<!-- section:executive-snapshot -->
## Executive Snapshot
**What it is:** Rescript is a therapeutic journaling app for iOS and Android that uses the Pennebaker Expressive Writing Protocol to guide users through emotional processing.
**Why users hire it:** Users hire Rescript to move beyond simple mood logging into structured, evidence-based emotional recovery, solving the problem of blank-page anxiety in traditional journals.
<!-- /section:executive-snapshot -->

<!-- section:features -->
## App DNA (Features & Intent)
- **[Differentiator] Pennebaker Expressive Writing Protocol:** Guided 4-day writing cycle based on clinical research.
  * *User Intent:* Users need clear guidance to understand and adopt the product quickly.
- **[Differentiator] AI Emotional Analysis:** Automated detection of tone shifts and language patterns to track progress.
  * *User Intent:* Users seek enhanced value through premium features.
- **[Standard] Mindful Journal Mode:** Daily guided prompts for ongoing mental maintenance.
  * *User Intent:* Users are motivated by consistent progression and daily incentives.
<!-- /section:features -->

<!-- section:market-position -->
## Market Position {#market-position}

Rescript enters a saturated lifestyle category where competitors like EMMO maintain high engagement through established community trust. The $39.99 annual price point positions it as a premium therapeutic tool rather than a casual daily logger.
<!-- /section:market-position -->

## Monetization Strategy
- **Model:** Subscription
- **Tiers:** Monthly: $9.99, Annual: $39.99
- **Analysis:** The annual tier offers a 67% discount to incentivize long-term commitment, which is critical for a protocol-based app requiring 4-day cycles.

<!-- section:swot -->
## SWOT Analysis {#swot}

**Core Strengths:**
- Clinical validation via Pennebaker Protocol
- AI-driven emotional arc tracking

**Critical Frictions:**
- High $39.99 annual subscription barrier
- Lack of established social network effects

**Growth Levers:**
- B2B distribution via mental health partnerships
- Wearable integration for stress-tracking triggers

**Market Threats:**
- Rapid AI-journaling feature parity from Ondo
- Established minimalist rivals like EMMO

<!-- /section:swot -->
## Recent Changes (v2 → v3) {#recent-changes}

The report reflects a strategic pivot toward premium positioning and protocol-focused onboarding, while acknowledging increased competitive pressure from AI-journaling and minimalist incumbents.

**Overall trend**: Mixed
**Compared at**: 2026-07-04

### High-impact changes
- **[Shifted] Premium Price Barrier** (pricing) — The $39.99 annual subscription is now explicitly categorized as a high barrier to entry, shifting the market narrative from a clinical tool to a premium therapeutic product.
- **[Shifted] Strategic Onboarding Pivot** (positioning) — PM action items shifted from general AI-dashboard development to protocol-specific onboarding and physical export logic to improve trial-to-paid conversion.

### Medium-impact changes
- **[Added] Competitive Threat Expansion** (swot) — Added specific threats from Ondo (AI feature parity) and EMMO (minimalist market dominance) to the SWOT analysis.
- **[Added] Expanded Feature Gap Benchmarking** (features) — Added specific feature gaps for story heatmaps (vs Shine) and task management (vs iMood) to the competitive analysis.

<!-- section:rivals -->
## Rivals Landscape {#rivals}

> Competitive positioning identified by AI analysis of app features, category, and market signals.

### Rescript: Therapeutic Journal vs EMMO - 日记与笔记 — Head to Head
- **EMMO - 日记与笔记** by EMMO Corp.: EMMO dominates the lifestyle journaling space with a massive user base and high engagement, directly competing for the same daily habit-forming audience as Rescript.
  - **Key differences:**
    - Massive established user base creates a strong social proof barrier for new entrants
    - Highly polished, minimalist aesthetic appeals to users prioritizing visual simplicity over clinical protocols
    - Deeply ingrained habit loop through years of consistent feature updates and community trust
  - **Where Rescript: Therapeutic Journal wins:**
    - ✅ Clinical validation through the Pennebaker Protocol provides a unique, science-backed value proposition
    - ✅ Focused therapeutic intent attracts users seeking specific mental health outcomes rather than general logging
  - **Where EMMO - 日记与笔记 wins:**
    - ❌ Vast, mature feature set offers superior flexibility for non-clinical daily journaling needs
    - ❌ Significant network effect and brand recognition make it the default choice for casual diarists
  - **Verdict:** Rescript should avoid a feature-parity war and instead double down on its clinical niche to attract users seeking measurable mental health improvements.

### Contenders (Strong Challengers)
- **[Shine - Timeline diary](https://marlvel.ai/apps/shine-timeline-diary)** by 晓松 高: Shine competes by visualizing emotional data through heatmaps, offering a data-driven alternative to Rescript’s protocol-driven approach.
  - Story heatmap visualization provides immediate, intuitive insights into long-term emotional trends
  - Voice diary functionality offers a faster, more accessible input method than text-heavy journaling
- **[团纸日记-把生活写成一本书](https://marlvel.ai/apps/tuanzhiriji-benben)** by Shanghai Ningguang Information Technology Co., Ltd.: This app targets the 'legacy' aspect of journaling, allowing users to export their digital entries into physical books, competing for the long-term archival user.
  - Physical book export service creates a tangible product value that digital-only apps lack
  - Timeline view provides a superior retrospective experience for users looking back at their history
- **[iMood-心情日记、待办清单](https://marlvel.ai/apps/imood)** by 继伟 王: iMood overlaps with Rescript by combining mood tracking with daily productivity, targeting users who want to link their emotional state to their tasks.
  - Integrated task management turns the journal into a functional productivity tool rather than just reflection
  - Customizable reminders help users maintain a daily streak more effectively than static prompts
- **[一叶日记·极简卡片心情记录日记](https://marlvel.ai/apps/justtoday-diary)** by 荣九 蔡: This app competes by offering a card-style interface that simplifies the journaling process, appealing to users who find long-form writing daunting.
  - Card-style UI provides a lower friction entry point compared to Rescript’s 20-minute protocol
  - Robust WebDAV and iCloud sync options offer better data portability for power users

### Peers (What They Do Better)
- **[Legacy Lab - Auto Book Creator](https://marlvel.ai/apps/legacy-lab-auto-book-creator)** by AutoBiographer, LLC: Legacy Lab focuses on the narrative output of journaling, competing for users who want to turn their life stories into a structured book.
  - Voice-to-text recording makes it easier for users to capture long-form narratives without typing
  - Automated book production service offers a premium, high-value physical output for users
- **[DrawMyToday - AI Picture Diary](https://marlvel.ai/apps/drawmytoday-ai-picture-diary)** by CHANHO LEE: This app targets the creative journaling segment, using AI to turn daily experiences into visual art rather than text.
  - AI-generated imagery transforms abstract feelings into visual art, appealing to non-writers
  - Encrypted storage provides a strong privacy-first selling point for sensitive personal reflections
- **[Ondo: AI Journal](https://marlvel.ai/apps/ondo-ai-journal)** by Onda Labs, Inc.: Ondo uses conversational AI to facilitate reflection, acting as a digital coach that mimics the therapeutic guidance Rescript aims to provide.
  - Conversational AI interface creates a more interactive, coaching-style experience than static writing prompts
  - Pattern recognition features provide automated insights into user behavior and emotional triggers
- **[My AI Journal](https://marlvel.ai/apps/my-ai-journal)** by Kento Umeki: This app uses AI to automate the journaling process, directly challenging Rescript's manual, protocol-based writing method.
  - AI-generated entries significantly reduce the cognitive load required to start a daily journal
  - Photo attachment integration provides a richer, multi-modal memory capture experience

### New Kids on the Block (What's Innovative)
- **[Lore: Every Chat Hides a Story](https://marlvel.ai/apps/lore-every-chat-hides-a-story)** by Amon Studio: Lore captures the 'journaling as conversation' trend by integrating with messaging apps to extract stories from daily chats.
  - WhatsApp chat integration automates the data collection process by pulling from existing conversations
- **[おうち新聞](https://marlvel.ai/apps/karmait-ouchishinbun)** by Ide Koshin: This newcomer focuses on family-oriented journaling, shifting the focus from individual therapy to collective family history.
  - Automated weekly newspaper format turns family updates into a fun, shareable digital publication

<!-- /section:rivals -->
<!-- section:momentum -->
## App Momentum (Zombie) {#momentum}

- Launched iOS and Android versions Mar 2026.
- Initial release focuses on core protocol.

> **Cadence:** 2 total versions · 0 majors in last 6 months · 93 days since last update · 0 days avg between updates

<!-- /section:momentum -->

<!-- section:so-what -->
## The "So What?" (Strategic Takeaway) {#so-what}

Rescript: Therapeutic Journal is an established lifestyle app that is available.

<!-- speakable-start -->
> **Bottom Line:** Rescript wins on clinical credibility but lacks the daily habit-forming mechanics of its rivals, so revenue growth hinges on proving the protocol's efficacy to users during the initial 4-day cycle.
<!-- speakable-end -->

**Best for:** Individuals seeking structured, evidence-based tools to process grief, trauma, or daily stress.

<!-- section:pm-actions -->
### PM Action Plan (Next Best Moves)

- [ ] [PIVOT] [HIGH IMPACT] Pivot onboarding to emphasize the 4-day protocol success rate — *Competitors like EMMO rely on habit loops, while Rescript's protocol requires specific user commitment → improve trial-to-paid conversion.* _(trade-off: deprioritize Pause the development of the Mindful Journal Mode expansion to focus on protocol-specific onboarding.)_
- [ ] [INVEST] [MEDIUM IMPACT] Invest in a physical export feature — *Competitors like Tuanzhi use physical book exports to justify subscription value → increase long-term retention.* _(trade-off: deprioritize Deprioritize the AI-generated imagery feature to allocate engineering hours to export logic.)_
<!-- /section:pm-actions -->

<!-- section:feature-gaps -->
### Feature Gaps vs Competitors

- Physical book export (available in Tuanzhi)
- Story heatmap visualization (available in Shine)
- Task management integration (available in iMood)
<!-- /section:feature-gaps -->

<!-- section:outlook -->
### Outlook: Mixed

The lifestyle journaling market is consolidating around apps that offer either extreme simplicity or tangible archival value. Rescript's clinical niche is defensible, but its success depends on whether users perceive the 4-day protocol as worth the premium subscription cost compared to free alternatives.

- ⚪ The app launched in late March 2026, meaning it currently lacks the user-base momentum to challenge established lifestyle category leaders.
- 🔴 The $39.99 annual price point creates a high barrier to entry, which may limit the top-of-funnel conversion required to compete with free-to-start rivals.
<!-- /section:outlook -->

<!-- /section:so-what -->

<!-- section:metrics -->
## Key Metrics Summary

| Metric | Value |
| :--- | :--- |
| Total Reviews | 0 |
| Confidence | Low |
| Pricing Model | Subscription |
| Platforms | iOS & Android |
| Key Features | 3 analyzed |
| Trend | Mixed |
| Outlook | Mixed |
<!-- /section:metrics -->

## Competitor Comparison

| App | Rating | Sentiment | Developer |
| :--- | :--- | :--- | :--- |
| **Rescript: Therapeutic Journal** (this app) | N/A/5 | N/A | Mangosteen Studio, LLC |
| [Lore: Every Chat Hides a Story](https://marlvel.ai/apps/lore-every-chat-hides-a-story) | N/A/5 | N/A | Amon Studio |
| [DrawMyToday - AI Picture Diary](https://marlvel.ai/apps/drawmytoday-ai-picture-diary) | 4.3/5 | Upset | CHANHO LEE |
| [Shine - Timeline diary](https://marlvel.ai/apps/shine-timeline-diary) | 4.0/5 | Thrilled | 晓松 高 |
| [My AI Journal](https://marlvel.ai/apps/my-ai-journal) | 5.0/5 | N/A | Kento Umeki |
| [Legacy Lab - Auto Book Creator](https://marlvel.ai/apps/legacy-lab-auto-book-creator) | 3.0/5 | Thrilled | AutoBiographer, LLC |

## Company Profile
- **Developer:** Mangosteen Studio, LLC

## Data Sources & Links
- **App Store:** [View on Apple Store](https://apps.apple.com/us/app/rescript-therapeutic-journal/id6760118814?uo=4)
- **Google Play:** [View on Google Play](https://play.google.com/store/apps/details?id=studio.mangosteen.rescriptjournal&hl=en&gl=us)
- **Sources:** App store metadata.

## Related Intel Reports
- [*Lore: Every Chat Hides a Story*](https://marlvel.ai/apps/lore-every-chat-hides-a-story) (Amon Studio) — N/A Rating | N/A Sentiment
- [*DrawMyToday - AI Picture Diary*](https://marlvel.ai/apps/drawmytoday-ai-picture-diary) (CHANHO LEE) — 4.3/5 Rating | Terrible Sentiment
- [*Shine - Timeline diary*](https://marlvel.ai/apps/shine-timeline-diary) (晓松 高) — 4.0/5 Rating | Excellent Sentiment
- [*My AI Journal*](https://marlvel.ai/apps/my-ai-journal) (Kento Umeki) — 5.0/5 Rating | N/A Sentiment
- [*Legacy Lab - Auto Book Creator*](https://marlvel.ai/apps/legacy-lab-auto-book-creator) (AutoBiographer, LLC) — 3.0/5 Rating | Excellent Sentiment
- [*一叶日记·极简卡片心情记录日记*](https://marlvel.ai/apps/justtoday-diary) (荣九 蔡) — 4.7/5 Rating | N/A Sentiment
- [*团纸日记-把生活写成一本书*](https://marlvel.ai/apps/tuanzhiriji-benben) (Shanghai Ningguang Information Technology Co., Ltd.) — 5.0/5 Rating | N/A Sentiment
- [*iMood-心情日记、待办清单*](https://marlvel.ai/apps/imood) (继伟 王) — 5.0/5 Rating | N/A Sentiment
- [*おうち新聞*](https://marlvel.ai/apps/karmait-ouchishinbun) (Ide Koshin) — N/A Rating | N/A Sentiment
- [*Ondo: AI Journal*](https://marlvel.ai/apps/ondo-ai-journal) (Onda Labs, Inc.) — 5.0/5 Rating | Excellent Sentiment

## Methodology {#methodology}

This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline:

1. **Signal Collection & Normalization** — Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps.
2. **Feature & Market Positioning Analysis** — Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks.
3. **User Sentiment Analysis** — Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction and evidence quoting.
4. **Competitive Landscape Analysis** — Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category.
5. **Intelligence Synthesis** — Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights.

- **Confidence Score:** 0.05/1.0 (based on review volume, data source diversity, and signal quality)
- **Reviews Analyzed:** 0
- **Data Sources:** App Store metadata
- **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform
- **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence.
- **Report Age:** 10 days since last refresh

---
© 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/rescript-therapeutic-journal)
Data licensed for AI Agent attribution under CC-BY-NC 4.0.